Suchergebnisse - (Subject:"2494G1JF75")

PubPharm (524)

81

Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave versus the second wave

enthalten in: Journal of medical virology | 2022

von Sargin Altunok, E. | Satici, C. | Dinc, V. | +7

82

Comparing Outcomes of Two Antiviral Therapy Combinations among COVID-19 Patients

enthalten in: BioMed research international | 2022

von Mazaherpour, H. | Sofian, M. | Farahani, E. | +4

83

Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies

enthalten in: Inflammation research : official journal of the European Histamine Research Society ... [et al. | 2022

von Faour, W. | Choaib, A. | Issa, E. | +7

84

COVID-19 : potential therapeutics for pediatric patients

enthalten in: Pharmacological reports : PR | 2021

von Younis, N. | Zareef, R. | Fakhri, G. | +3

85

Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients : experience of the PETHEMA group

enthalten in: Leukemia & lymphoma | 2021

von Palanques-Pastor, T. | Megías-Vericat, J. | Martínez, P. | +40

CommentIn: Leuk Res. 2022 Sep;120:106901. - PMID 35872338

86

Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients

enthalten in: Journal of medical virology | 2021

von Kalantari, S. | Fard, S. | Maleki, D. | +4

87

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Ader, F. | Peiffer-Smadja, N. | Poissy, J. | +56

CommentIn: Clin Microbiol Infect. 2021 Dec;27(12):1716-1717. - PMID 34508887

88

Combining subsidiary and synchronous approaches for concurrent spectrofluorimetric assurance of lopinavir and ritonavir in tablets utilized in convention for treatment of coronavirus infection (COVID-19) and biological fluids

enthalten in: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy | 2021

von Salem, H. | Samir, E. | Abdelaziz, A. | +4

89

A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State : study protocol for a randomized controlled trial

enthalten in: Trials | 2021

von Abayomi, A. | Osibogun, A. | Ezechi, O. | +8

90

Harnessing stress granule formation by small molecules to inhibit the cellular replication of SARS-CoV-2

enthalten in: Chemical communications (Cambridge, England) | 2021

von Byun, W. | Lee, J. | Kim, S. | +1